Privia Health Group (NASDAQ:PRVA) Now Covered by BMO Capital Markets

BMO Capital Markets started coverage on shares of Privia Health Group (NASDAQ:PRVA) in a report issued on Thursday, MarketBeat reports. The firm issued an outperform rating and a $30.00 price objective on the stock.

A number of other brokerages have also recently issued reports on PRVA. Citizens Jmp upped their price objective on shares of Privia Health Group from $30.00 to $31.00 and gave the stock a “market outperform” rating in a report on Friday, November 7th. Citigroup reaffirmed an “outperform” rating on shares of Privia Health Group in a research report on Friday, August 29th. Barclays increased their price objective on Privia Health Group from $22.00 to $23.00 and gave the company an “equal weight” rating in a report on Monday. Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. Finally, Weiss Ratings raised Privia Health Group from a “sell (d+)” rating to a “hold (c)” rating in a research report on Friday, November 7th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $30.00.

Privia Health Group Price Performance

PRVA traded down $0.30 during trading on Thursday, reaching $23.45. 707,221 shares of the stock traded hands, compared to its average volume of 849,076. The stock’s 50-day simple moving average is $24.21 and its two-hundred day simple moving average is $22.79. Privia Health Group has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The stock has a market cap of $2.88 billion, a price-to-earnings ratio of 180.40, a price-to-earnings-growth ratio of 3.96 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. The company had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%. Research analysts anticipate that Privia Health Group will post 0.14 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Privia Health Group

A number of institutional investors have recently added to or reduced their stakes in PRVA. CWM LLC grew its stake in shares of Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after purchasing an additional 604 shares during the period. Russell Investments Group Ltd. grew its position in Privia Health Group by 2,852.2% in the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock valued at $60,000 after acquiring an additional 2,567 shares during the period. Caitong International Asset Management Co. Ltd grew its position in Privia Health Group by 2,115.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock valued at $75,000 after acquiring an additional 3,173 shares during the period. Vestcor Inc acquired a new position in Privia Health Group during the first quarter worth $76,000. Finally, Canada Pension Plan Investment Board lifted its holdings in shares of Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after acquiring an additional 1,200 shares during the period. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.